Legal & General Group PLC Seagen Inc. Transaction History

Legal & General Group PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $496,968 - $560,935	2,595 Added 0.29%	888,995 $189 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $14.5 Million - $15.9 Million	77,328 Added 9.56%	886,400 $171 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $1.93 Million - $3.07 Million	15,113 Added 1.9%	809,072 $164 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $2.54 Million - $3.01 Million	-21,656 Reduced 2.66%	793,959 $102 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $2.8 Million - $3.73 Million	-20,689 Reduced 2.47%	815,615 $112 Million
Q2 2022 Aug 22, 2022	SELL	$108.81 - $179.33 $3.5 Million - $5.77 Million	-32,201 Reduced 3.71%	836,304 $148 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $6.75 Million - $8.91 Million	56,439 Added 6.95%	868,505 $125 Million
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $4.31 Million - $5.77 Million	-30,226 Reduced 3.59%	812,066 $126 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $116,808 - $139,252	820 Added 0.1%	842,292 $143 Million
Q2 2021 Aug 12, 2021	BUY	$135.08 - $161.1 $13.9 Million - $16.6 Million	102,917 Added 13.93%	841,472 $133 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $822,309 - $1.14 Million	5,980 Added 0.82%	738,555 $103 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $121 Million - $155 Million	732,575 New	732,575 $128 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.